Krystal Biotech CEO says company is "insulated" from macroeconomic tailwinds due to domestic manufacturing capabilities
The company's CEO acknowledged a "turbulent macro and FDA backdrop" on its first quarter earnings call.
The company's CEO acknowledged a "turbulent macro and FDA backdrop" on its first quarter earnings call.